Publications

Research outputs, reports, policy briefs and knowledge products from KIU scholars and partners.

Knowledge Outputs

Featured publications

Publication records can include DOI links, downloads, authors, abstracts and indexing data.

Reset
5,279 results found Records are sourced from the KIU Publications module.
2026 School of Pharmacy

Population Genomics for Breast Cancer: Return of Results, Cascade Testing, and Health System Readiness from Bench-to-Population Perspectives

Ssenkayi Julius

2026 | IAA Journal of Biological Sciences | Pp. 133-141

Population genomics is reshaping breast cancer prevention by enabling the identification of individuals and families at elevated genetic risk before disease onset. Advances in genomic technologies have made populationscale screening for high-penetrance breast...

2026 School of Pharmacy

Polygenic Risk Scores for Breast Cancer in African Ancestry Populations: Transferability, Calibration, and Decision Thresholds

Ssenkayi Julius

2026 | IAA Journal of Biological Sciences | Pp. 125-132

Polygenic risk scores (PRS) have emerged as promising tools for stratifying breast cancer risk and informing screening and prevention strategies. However, their clinical utility in African ancestry populations remains limited due to poor transferability, misc...

2026 Faculty of Clinical Medicine and Dentistry

Oxidative Stress Pathways in Diabetes: Novel Insights Into Antioxidant Defense Failure

Tom Robert

2026 | IAA Journal of Applied Sciences | Pp. 18-23

Oxidative stress is a defining molecular hallmark of diabetes mellitus and its complications. Both type 1 and type 2 diabetes are characterized by excessive production of reactive oxygen species (ROS), chronic low-grade inflammation, mitochondrial dysfunction...

2026 School of Pharmacy

Newborn Screening Expansion through Metabolomics: Evaluating Benefits, Harms, and Decision Frameworks for Public Health

Serunjogi Ruth

2026 | IAA Journal of Biological Sciences | Pp. 114-124

Newborn screening is a cornerstone of preventive public health, enabling the early identification of congenital and metabolic disorders for which timely intervention can substantially reduce morbidity and mortality. Advances in metabolomics now present an opp...

2026 Faculty of Clinical Medicine and Dentistry

Mitochondrial Dysfunction in Type 2 Diabetes: Implications for Immunity and Organ Toxicity

Chelimo Faith Rebecca

2026 | IAA Journal of Applied Sciences | Pp. 36-43

Mitochondrial dysfunction has emerged as a central mechanism linking metabolic derangements, immune dysregulation, and multi-organ toxicity in Type 2 Diabetes Mellitus (T2DM). Beyond its classical features of insulin resistance and hyperglycaemia, T2DM is cha...

2026 School of Pharmacy

Integrating www.iaajournals.org ISSN:2636-7254 IAAJB1411 Long-Read Sequencing with Imaging Biomarkers for Stroke Risk Prediction: Interpretability, Bias, and Real-World Performance with Implementation and Equity Considerations

Serunjogi Ruth

2026 | IAA Journal of Biological Sciences | Pp. 87-97

Ischemic stroke remains a leading cause of mortality and long-term disability worldwide, with risk prediction constrained by incomplete characterization of biological heterogeneity and limited integration of high-dimensional data. Advances in long-read genomi...

2026 Faculty of Clinical Medicine and Dentistry

Hyperglycaemia-Induced ROS and Immune Dysfunction: A Comprehensive Review

Tom Robert

2026 | IAA Journal of Applied Sciences | Pp. 24-29

Hyperglycaemia is a defining biochemical hallmark of diabetes mellitus and exerts profound effects on cellular redox homeostasis and immune function. Sustained elevations in blood glucose promote excessive generation of reactive oxygen species (ROS) through m...

2026 School of Pharmacy

Gut Microbiota–Nanotechnology Interface: A New Frontier in Managing Obesity and Diabetes

Winniefred Nankya

2026 | IAA Journal of Biological Sciences | Pp. 82-86

The gut microbiota plays a crucial role in maintaining metabolic homeostasis and influencing the development of obesity and type 2 diabetes (T2D). Dysbiosis, an imbalance in gut microbial composition, has been linked to insulin resistance, inflammation, and d...

2026 School of Pharmacy

Gut Microbial Bile Acid Signaling as a Shared Therapeutic Axis in Obesity and Diabetes

Winniefred Nankya

2026 | IAA Journal of Biological Sciences | Pp. 75-81

Bile acids (BAs) have emerged as pleiotropic signaling molecules that connect gut microbiota, liver, intestine, and peripheral metabolic tissues. Beyond their classical role in lipid absorption, BAs act as endocrine regulators via receptors such as the farnes...

2026 School of Pharmacy

Glucagon Receptor Antagonists versus Standard Care: Beta-Cell Preservation in Early Type 1 Diabetes

Mercy Latricia

2026 | IAA Journal of Biological Sciences | Pp. 60-64

Type 1 diabetes mellitus was characterized by autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency and lifelong dependence on exogenous insulin therapy. Emerging evidence suggested that glucagon signaling contributed to hype...